Disturbances in NAMPT and NAMPT-mediated NAD+ biosynthesis have been reported to contribute to the development of non-alcoholic fatty liver disease (NAFLD) and NAMPT is implicated in the regulation of hepatic lipid metabolism[14–16, 19]. The gene discussed is NAMPT; the disease is metabolic dysfunction-associated steatotic liver disease.